Biocartis, molecular diagnostics company, said it has signed an agreement with Royal Philips Electronics to acquire its technology platform for rapid fully-automated DNA/RNA molecular diagnostic testing.
The platform has been designed for applications in a wide range of patient sample testing, including oncology and infectious diseases.
Biocartis said under the deal it will develop and commercialize the [...]












Recent Comments